From Meme to Million: Pullix (PLX) Presale Gains Tractionby John Darbie 16.02.2024Pullix (PLX) presale gains traction as investors see promising investment opportunity. Project solves liquidity and transaction fee issues, attracting over ...
XRP’s Path to $5.53: Market Cap Shifts and Ethereum’s Standby John Darbie 16.02.2024XRP's market cap continues to slide, now sitting at sixth place. Ethereum remains in second place, but XRP could see ...
MGX Unveils Game-Changing Printable Substrate Techby Lilu Anderson 16.02.2024MGX introduces newly reformulated dry toner coating technology to enhance print quality and durability of specialty substrates. The innovation is ...
Apple Vision Pro Returns Spike: Hype Fadesby Lilu Anderson 16.02.2024Early adopters of the Apple Vision Pro virtual-reality headset are returning their units as the 14-day refund deadline approaches. The ...
Franklin BSP Realty Trust: Earnings Growth Signals Strong Futureby Terry Bingman 16.02.2024Franklin BSP Realty Trust (FBRT) has reported strong growth in earnings and investment portfolio for Q4 and full year 2023, ...
Ethereum’s Surge Sparks Record Liquidation, Eyes $2,800by John Darbie 16.02.2024Ethereum's surge fuels significant liquidation volume, pushing it towards $2,800 as traders exhibit confidence and market dominance.
Jeff Bezos Sells $6B in Amazon Shares: What’s Next?by Mark Eisenberg 16.02.2024Jeff Bezos sells $2.03 billion worth of Amazon shares, bringing his monthly sales to $6 billion, raising concerns about Amazon's ...
StoneX Group Seals $550M Bond Deal for Financial Stabilityby Terry Bingman 16.02.2024Leading financial services organization, StoneX Group, prices $550 million offering of 7.875% Senior Secured Notes due in 2031. Proceeds will ...
Meta vs. Apple: The Battle Over Ad Fees Escalatesby Lilu Anderson 16.02.2024Meta Platforms and Apple are locked in a battle over advertiser charges on iOS. Meta's guidelines to help advertisers avoid ...
FTC Probe into Big Pharma Sparks Drug Price Surgeby Mark Eisenberg 16.02.2024Health-care companies are rallying amid expectations of higher drug prices and ongoing pharmaceutical shortages in the US. The FTC is ...